Non-Hodgkin's ovarian lymphoma during adolescence: report of two cases.
OBJECTIVE
To present two cases of non-Hodgkin's ovarian lymphoma during adolescence.


METHODS
Follow up of the patients. Report of diagnostic and therapeutic approaches.


METHODS
Division of Pediatric and Adolescent Gynecology and Corrective Gynecological Surgery, University of Athens (Athens, Greece).


METHODS
Laparotomy and chemotherapy. RESULTS AND MAIN OUTCOME: Three- and five-year survival rates.


CONCLUSIONS
Ovarian lymphoma constitutes a rare entity with guarded prognosis. Selective surgery and chemotherapy constitute the treatment of choice.
Creatsas
G K
GK
First Department of Obstetrics and Gynecology, University of Athens, Alexandra Hospital, Greece.
Hassan
E A
EA
Deligeoroglou
E K
EK
Markaki
S G
SG
Michalas
S P
SP
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002051:Burkitt Lymphoma / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D008727:Methotrexate / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D011241:Prednisone; D008727:Methotrexate